This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

A Case Report of Photosensitivity to Amisulpride

Laurence Borras, MD, and Philippe Huguelet, PD

Published: April 16, 2007

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Amisulpride is a second-generation antipsychotic approvedas monotherapy for treatment of refractory schizophrenia.1 It acts with a unique pharmacologic profile that haspreferential affinity for D2/D3 receptors and specificity forlimbic rather than striatal structures. Very few side effects ofamisulpride therapy, and none with a dermatologic nature, havebeen reported.2

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 9

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...